Thermo Fisher Scientific Inc. (LON:0R0H)
London
· Delayed Price · Currency is GBP · Price in USD | Market Cap | 113.81B |
| Revenue (ttm) | 33.14B |
| Net Income (ttm) | 5.03B |
| Shares Out | n/a |
| EPS (ttm) | 13.17 |
| PE Ratio | 22.62 |
| Forward PE | 17.99 |
| Dividend | 1.25 (0.32%) |
| Ex-Dividend Date | Jun 13, 2025 |
| Volume | 1,782 |
| Average Volume | 1,452 |
| Open | 396.85 |
| Previous Close | 393.77 |
| Day's Range | 390.81 - 396.87 |
| 52-Week Range | 385.88 - 627.50 |
| Beta | 0.78 |
| RSI | 44.57 |
| Earnings Date | Jul 23, 2025 |
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company’s Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery and production of drugs and vaccines, as well as diagnosis of infections and diseases. Its Analytical Instruments segment provides instruments, consumables, software, and services for phar... [Read more]
Financial Performance
In 2024, Thermo Fisher Scientific's revenue was $42.88 billion, an increase of 0.05% compared to the previous year's $42.86 billion. Earnings were $6.34 billion, an increase of 5.67%.
Financial numbers in USD Financial StatementsNews
Xcell Biosciences Announces Joint Research Collaboration with Thermo Fisher Scientific to Advance the Next Generation of Cell Therapies
SAN FRANCISCO--(BUSINESS WIRE)--Xcell Biosciences (Xcellbio), a San Francisco-based instrumentation company focused on cell and gene therapy applications, today announced a strategic collaboration wit...
Thermo Fisher Scientific Awarded $94.5 Million U.S. Government Contract to Supply the Navy with Advanced Radiation Detection Systems
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, today announced that it has been awarded a five-year, $94.5 million contract by the U.S. Department of D...
3Q Investing Outlook: Why Farmer Likes PEP, TMO, UNH
Karl Farmer says investors have to "be comfortable with short-term volatility" as the markets approach the 3Q. He's looking to any modifications coming to the Trump Administration's 90-day tariff paus...
Neurophotonics Research & Therapeutics Market 2025-2029: Global and Regional Analysis by Type and End User Featuring Carl Zeiss, Femtonics, Hitachi, Thermo Fisher Scientific and More
Dublin, June 20, 2025 (GLOBE NEWSWIRE) -- The "Neurophotonics Market 2025-2029" report has been added to ResearchAndMarkets.com's offering.
Recent Report Shows That Rep. Rick Allen Bought Up to $65K Worth of Netflix Stock
June 18, 2025 records indicate that Representative Rick Allen filed a purchase of Netflix (NASDAQ: NFLX), valued between $16,002 and $65,000. According to the June filing, the transaction occurred on...
How Is The Market Feeling About Thermo Fisher Scientific?
Thermo Fisher Scientific's (NYSE: TMO) short percent of float has risen 4.13% since its last report. The company recently reported that it has 4.74 million shares sold short , which is 1.26% of all r...
Tufts Center Study Shows Significant Time Savings in Delivering Therapies to Patients with Thermo Fisher Scientific's Accelerator™ Drug Development 360° CDMO and CRO Solutions
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today announced the findings of new research by the Tufts Center for the Study of Drug Development ...
Notable healthcare headlines for the week: Novo Nordisk, Thermo Fisher and UnitedHealth in focus
Report: Biotech Research Firm Thermo Fisher Considers Selling Diagnostics Business
Biotechnology research firm Thermo Fisher Scientific is reportedly looking to sell part of its diagnostics business amid industrywide concerns about federal cutbacks in spending on research.
Ethris Signs Strategic Collaboration with Thermo Fisher Scientific to Provide Access to mRNA Technology Platforms
MUNICH--(BUSINESS WIRE)--Ethris GmbH, a clinical-stage biotechnology company pioneering next-generation RNA therapeutics and vaccines, today announced a strategic collaboration with Thermo Fisher Scie...
Thermo Fisher said to weigh sale of some diagnostic assets for $4B
Thermo Fisher plans to sell parts of diagnostics unit for $4 billion, FT reports
Thermo Fisher Scientific plans to sell its diagnostics unit for about $4 billion in an attempt to offload some of its low-growth assets, the Financial Times reported on Thursday, citing people familia...
Thermo Fisher aims to sell parts of its diagnostics business for $4bn
Deal would mark latest move by a life sciences group to jettison lower-growth assets
Supply Chain Leaders to Share Perspective on Tackling Tariffs, Trade, and Disruption During Exclusive Digital Event
Experts from Qualcomm, Viant Medical, and Thermo Fisher Scientific join Kinaxis and economic futurist Andrew Busch to share insights on navigating tariff volatility OTTAWA, Ontario — As global trade t...
Price Over Earnings Overview: Thermo Fisher Scientific
In the current market session, Thermo Fisher Scientific Inc. (NYSE: TMO) price is at $401.51, after a 1.27% spike. However, over the past month, the stock fell by 1.35% , and in the past year, by 30....
Thermo Fisher Scientific Unveils Next-generation Mass Spectrometers at ASMS 2025 to Revolutionize Biopharma Applications and Omics Research
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced the launch of the Thermo Scientific™ Orbitrap™ Astral™ Zoom mass spectr...
Thermo Fisher: With A 30% Price Drop, Trump Legislation, And High Capex, Is It Undervalued?
Thermo Fisher Is Strengthening Its Long-Term Advantage
So Cheap It's Silly - 2 Dividend Stocks I'd Buy Twice If I Could
Market extremes often drive flawed narratives. Many investors get spooked by sell-offs or seduced by overvaluations, when real opportunity hides in discomfort. While today's market isn't euphoric, it'...
Thermo Fisher Scientific Launches New Spectral Flow Cytometer Offering Increased Speed, Versatility and Reliability to Labs
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today launched the spectral-enabled Invitrogen™ Attune™ Xenith™ Flow Cytometer, allowing immunology...
Thermo Fisher Scientific Stock: Big Upside Potential After Sluggishness Through November?
Thermo Fisher Scientific Inc. (NYSE: TMO) is currently navigating a rare and telling phase in its journey through the Adhishthana Cycle. The stock is in its 18th Phase, simultaneously on both the wee...
Thermo Fisher Scientific Stock: Big Upside Potential After Sluggishness Through November?
Thermo Fisher Scientific Inc. TMO is currently navigating a rare and telling phase in its journey through the Adhishthana Cycle. The stock is in its 18th Phase, simultaneously on both the weekly and m...
Thermo Fisher Scientific Celebrates Precision Oncology Advancement at ASCO 2025
CARLSBAD, Calif.--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, will showcase some of the technologies that have helped power precision oncology at the 2025 American ...
$1000 Invested In Thermo Fisher Scientific 10 Years Ago Would Be Worth This Much Today
Thermo Fisher Scientific (NYSE: TMO) has outperformed the market over the past 10 years by 1.16% on an annualized basis producing an average annual return of 11.71%. Currently, Thermo Fisher Scientif...
Thermo Fisher Scientific Introduces Next Generation TruNarc Handheld Narcotics Analyzers to Support Public Safety
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, today introduced the Thermo Scientific™ TruNarc™ Delta and Tau Handheld Narcotics Analyzers* to help com...